Edgen Stock·Dec 16 2025, 00:07返回
吉利德愛滋病藥物在3期臨床試驗中取得成功
Edgen Stock·Dec 16 2025, 00:07
[1] 減肥藥臨床試驗顯示平均體重減輕30% - 藥學雜誌 (https://pharmaceutical-journal.com/article/ne ...)[2] Argenyx的Vyvgart在甲狀腺眼病三期試驗中失敗，增加正在進行的試驗風險 - BioSpace (https://www.biospace.com/drug-development/arg ...)[3] Immunome憑藉Desmoid腫瘤藥物在三期掃描後前往FDA - BioSpace (https://www.biospace.com/drug-development/imm ...)
